The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health and Prevention (MOHAP) of UAE. Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. The single-dose […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA).Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. Immunization with Sputnik Light in Egypt will […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved under the emergency use authorization procedure by the Food and Drug Administration (FDA) of the Republic of the Philippines. Sputnik Light vaccine based on human adenovirus serotype 26 is the first component […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data from Paraguay’s Ministry of Health on the one shot Russian Sputnik Light vaccine (the first component of the Sputnik V vaccine) demonstrating high safety profile and a 93.5% efficacy, as reported during the ongoing vaccination campaign in the country. The one shot […]
